Dequest 2010 en es it fr

Dequest 2010 Brand names, Dequest 2010 Analogs

Dequest 2010 Brand Names Mixture

  • No information avaliable

Dequest 2010 Chemical_Formula


Dequest 2010 RX_link

Dequest 2010 fda sheet

Dequest 2010 msds (material safety sheet)

Dequest 2010 Synthesis Reference

No information avaliable

Dequest 2010 Molecular Weight

391.46 g/mol

Dequest 2010 Melting Point

No information avaliable

Dequest 2010 H2O Solubility

10 mg/L

Dequest 2010 State


Dequest 2010 LogP


Dequest 2010 Dosage Forms

Tablets (100 mg)

Dequest 2010 Indication

For symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.

Dequest 2010 Pharmacology

Flavoxate is a spasmolytic flavone derivative that acts by relaxing the smooth muscle in the urinary tract. Flavoxate is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Muscarinic receptors play an important role in several major cholin-ergically mediated functions, including contractions of urinary bladder smooth muscle and stimulation of salivary secretion.

Dequest 2010 Absorption

Well absorbed from gastrointestinal tract.

Dequest 2010 side effects and Toxicity

The oral LD50 for flavoxate HCl in rats is 4273 mg/kg. The oral LD50 for flavoxate HCl in mice is 1837 mg/kg. Symptoms of overdose include convulsions, decreased ability to sweat, (warm, red skin, dry mouth, and increased body temperature), hallucinations, increased heart rate and blood pressure, and mental confusion.

Dequest 2010 Patient Information

Dequest 2010 Organisms Affected

Humans and other mammals